Abstract:
Apparatus is provided for removing plaque from a blood vessel of a subject, including a catheter shaped to define an opening that is placed in the blood vessel. A pressure source propels a fluid jet through the opening, and a pressure sensor detects a pressure in the blood vessel induced by the jet. A control unit steers the jet in response to the detected pressure. Other embodiments are also described.
Abstract:
A fuel cell system comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode configured as an air cathode and a separator interposed between said anode and said cathode, operable by an amine-derived fuel and oxygen (or air) is disclosed. Further disclosed are fuel cell systems comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode and a separator interposed between said anode and said cathode, which are operable by a mixture of two types of amine-derived compounds (e.g., ammonia borane, hydrazine and derivatives thereof). Also disclosed are methods of producing electric energy by, and electric-consuming devices containing and operable by, the disclosed fuel cell systems.
Abstract:
A fuel cell system comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode configured as an air cathode and a separator interposed between said anode and said cathode, operable by an amine-derived fuel and oxygen (or air) is disclosed. Further disclosed are fuel cell systems comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode and a separator interposed between said anode and said cathode, which are operable by a mixture of two types of amine-derived compounds (e.g., ammonia borane, hydrazine and derivatives thereof). Also disclosed are methods of producing electric energy by, and electric-consuming devices containing and operable by, the disclosed fuel cell systems.
Abstract:
A sterile artificial bone product is provided. The sterile artificial bone product comprises a sintered porous ceramic foam material having a density of 0.3 to 1.5 g/cc, and a porosity of 40 to 95%, pores of the material having a pore diameter distribution of 10-500 microns. Additionally, a bioactive compound is coupled to the ceramic foam material. Other embodiments are also described.